Copyright
©The Author(s) 2017.
World J Clin Oncol. Apr 10, 2017; 8(2): 100-105
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.100
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.100
Figure 2 Hypothetical representation of different groups of patients and their patterns of response to first line treatment: Primary refractory patients with early progression and high tumor growth rate, intermediate progressors with intermediate tumor growth rate, very slow progressors with low tumor growth rate and late progressors with high tumor growth rate.
TGR: Tumor-growth rate.
- Citation: Grande E, Martínez-Sáez O, Gajate-Borau P, Alonso-Gordoa T. Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate. World J Clin Oncol 2017; 8(2): 100-105
- URL: https://www.wjgnet.com/2218-4333/full/v8/i2/100.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i2.100